Literature DB >> 24365584

Association between IL12B polymorphisms and tuberculosis risk: a meta-analysis.

Guoyuan Liu1, Guanghua Li2, Ying Xu3, Na Song3, Suqin Shen3, Deke Jiang3, Wenjiao Zeng4, Honghai Wang5.   

Abstract

The interleukin (IL) 12B gene encodes p40, the subunit of both IL-12 and IL-23, which are important regulators of the type I T helper cell (TH1) immune response. IL12B 3' UTR and promoter polymorphisms have been reported to be correlated with IL-12 p40 production and have been suggested to be associated with TB (tuberculosis) susceptibility. Studies that have investigated the associations between these polymorphisms and TB risk have reported conflicting results. In this study, we performed a meta-analysis with 11 case-control studies (2897 cases/2653 controls) for the IL12B 3' UTR polymorphism and four case-control studies (1037 cases/1126 controls) for the IL12B promoter polymorphism to explore a more precise estimate of these associations. Crude odds ratios with 95% confidence intervals were assessed for the association using fixed- and random-effects models. For the IL12B 3' UTR variant, no significant associations were observed in genotypic and allelic tests in the overall analysis. A stratified analysis by ethnicity showed a significant association in Caucasians in dominant model models AC+CC vs. AA (OR=0.69, 95% CI: 0.51-0.93, p=0.015, P(heterogeneity) = 0.818). The allelic contrast indicated significant effects of the C allele on TB risk in Caucasians (OR=0.74, 95% CI: 0.58-0.95, p=0.019, P(heterogeneity) = 0.377), whereas such effects were not observed in Asians or in Africans. For the IL12B promoter variant, no significant associations were observed in either genotypic or allelic tests with the limited data that were available. This meta-analysis suggests that the C allele of the IL12B 3' UTR may act as a TB risk factor in Caucasians but not in Asians or in Africans. The effect of IL12B polymorphisms on TB risk might be influenced by ethnicity. To further confirm our findings, well-designed studies with large sample sizes and representing different ethnicities are required.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  IL12B 3′ UTR; IL12B promoter; Meta-analysis; Polymorphism; Tuberculosis

Mesh:

Substances:

Year:  2013        PMID: 24365584     DOI: 10.1016/j.meegid.2013.12.008

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  6 in total

Review 1.  Do HLA class II genes protect against pulmonary tuberculosis? A systematic review and meta-analysis.

Authors:  A Oliveira-Cortez; A C Melo; V E Chaves; A Condino-Neto; P Camargos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-13       Impact factor: 3.267

Review 2.  The association between the CC chemokine ligand 5 -28C>G gene polymorphism and tuberculosis susceptibility.

Authors:  Hongfang Lu; Jingang Wang; Baoan Gao; Shixiong Chen; Guangming Xiang; Shaojuan Yang; Yuan Gong; Li Guan
Journal:  Saudi Med J       Date:  2015-12       Impact factor: 1.484

3.  The IFNG rs1861494 Single Nucleotide Polymorphism Is Associated with Protection against Tuberculosis Disease in Argentina.

Authors:  Agustín Rolandelli; Joaquín M Pellegrini; Nicolás O Amiano; María C Santilli; María P Morelli; Florencia A Castello; Nancy L Tateosian; Alberto Levi; Nicolás Casco; Domingo J Palmero; Verónica E García
Journal:  Genes (Basel)       Date:  2018-01-22       Impact factor: 4.096

4.  Polymorphisms of cytokine genes and tuberculosis in two independent studies.

Authors:  Shouquan Wu; Ming-Gui Wang; Yu Wang; Jian-Qing He
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

5.  Genetic Polymorphisms of IFNG and IFNGR1 with Latent Tuberculosis Infection.

Authors:  Shouquan Wu; Xiangmin Liu; Yu Wang; Miaomiao Zhang; Minggui Wang; Jian-Qing He
Journal:  Dis Markers       Date:  2019-10-10       Impact factor: 3.434

6.  Gaps in Study Design for Immune Parameter Research for Latent Tuberculosis Infection: A Systematic Review.

Authors:  Mariana Herrera; Cristian Vera; Yoav Keynan; Zulma Vanessa Rueda
Journal:  J Immunol Res       Date:  2020-04-21       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.